In another study, activation of EGFR led to decreased protein levels of DSC3, whereas EGFR inhibition resulted in enhanced expression of DSC3, indicating an EGFR-dependent regulation of DSC3 in lung cancer. This evidence concerns the gene DSC3 and lung carcinoma.